NCT06697197 2026-02-03
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1/2 Recruiting
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd
Canadian Cancer Trials Group
Bristol-Myers Squibb
Fox Chase Cancer Center